Home » Newsletters » BioWorld Science

BioWorld Science

March 6, 1998

View Archived Issues

PKC antisense oligonucleotide shows promise in cancer therapy

Pharmacia & Upjohn: Q4 1997 highlights

Promotion agreement established for wound-healing drugs

Xoma: Q4 and year-end 1997 highlights

AxyS Pharmaceuticals: Q4 and year-end 1997 highlights

FDA approves expanded indications for Dynabac

Intercardia to acquire Transcell

Matritech: Q4 and year-end 1997 highlights

Hexagen and Genzyme Molecular Oncology establish SAGE agreement

Atrix: Q4 and year-end 1997 highlights

Succinamide derivatives for inhibiting MMPs and/or TNF production

Antitumor agents isolated from fungal strains by Roche

HMR prepares new antibacterial agents for Gram-positive infections

Astra develops new gastric antisecretory agents

Pharmacia & Upjohn presents new tyrosine kinase inhibitors

Xanthene derivatives useful for neurodegenerative disorders

Arthritis Advisory Committee meets later this month

Second market introduction for lercanidipine

FDA will give priority review to nitazoxanide

Droxia approved by FDA for sickle cell anemia

Receptagen and Scitech Genetics terminate merger proceedings

Forbes Medi-Tech files patent application covering AD prevention

AnervaX peptide vaccine successfully completes phase IIa trial

New indication for Mobic cleared by U.K. authorities

Targeted apoptosis as a novel therapeutic strategy in vascular disease

Preliminary results reported from phase II trials of Vitrase

Yamanouchi engages in NK antagonist research

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...